Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
The screening of cannabis addiction using machine learning, MoCA, and anxiety/depression tests (Scientific African, May 5, 2024)
Effects of psychedelic microdosing versus conventional ADHD medication use on emotion regulation, empathy, and ADHD symptoms in adults with severe ADHD symptoms: A naturalistic prospective comparison study (European Psychiatry, May 3, 2024)
An acute phase reaction from zoledronate mimicking symptoms seen in opioid withdrawal: a case report (Addiction Science and Clinical Practice, May 2, 2024)
Editorial: Confronting Addiction from Prevention to Recovery (ASAM, April 30, 2024)
Association of regular opioid use with incident dementia and neuroimaging markers of brain health in chronic pain patients (American Journal of Geriatric Psychiatry, April 30, 2024)
ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (ASAM, April 30, 2024)
Hospital admissions among patients with Comorbid Substance Use disorders: a secondary analysis of predictors from the NavSTAR Trial (Addiction Science and Clinical Practice, April 29, 2024)
Associations of cannabis use, use frequency, and cannabis use disorder with violent behavior among young adults in the United States (International Journal of Drug Policy, August 28, 2024)
Chronic Cannabis Use in Everyday Life: Emotional, Motivational, and Self-Regulatory Effects of Frequently Getting High (Social Psychological Personality Science, April 27, 2024)
Contextual barriers and enablers to establishing an addiction-focused consultation team for hospitalized adults with opioid use disorder (Addiction Science and Clinical Practice, August 27, 2024)
Higher First 30-Day Dose of Buprenorphine for Opioid Use Disorder Treatment Is Associated With Decreased Mortality (Journal of Addiction Medicine, April 26, 2024)
Withdrawal during outpatient low dose buprenorphine initiation in people who use fentanyl: a retrospective cohort study (Harm Reduction Journal, April 26, 2024)
Overdose from Unintentional Fentanyl Use when Intending to Use a Non-opioid Substance (Journal of Urban Health, April 26, 2024)
Personality changes related to presence and treatment of substance use (disorders): a systematic review (Psychological Medicine, April 24, 2024)
Relationships of State Alcohol Policy Environments with Homicides and Suicides (American Journal of Preventative Medicine, April 24, 2024)
Perinatal substance use disorder: examining the impact on adverse pregnancy outcomes (European Journal of Obstetrics and Gynecology, April 23, 2024)
Opioid Overdose Knowledge Among Adolescents and Young Adults (Free pdf download, JAMA Pediatrics, April 22, 2024)
Digital Interventions for Recreational Cannabis Use Among Young Adults (JMIR Publications, April 21, 2024)
Internet-delivered therapy for alcohol misuse: engagement, satisfaction, and outcomes when patients select their preference for therapist- or self-guided treatment (Addiction Science and Clinical Practice, April 21, 2024)
Perioperative Cannabinoids Significantly Reduce Postoperative Opioid Requirements in Patients Undergoing Coronary Artery Bypass Graft Surgery ( Cureus, April 20, 2024)
Alprazolam exposure during adolescence induces long-lasting dysregulation in reward sensitivity to morphine and second messenger signaling in the VTA-NAc pathway (Nature Scientific Reports, April 19, 2024)
Online surveillance of novel psychoactive substances (NPS): Monitoring Reddit discussions as a predictor of increased NPS-related exposures (Intenational Journal of Drug Policy, April 19, 2024)
NDEWS Report: Insights into pentobarbital (NIDA, April 19, 2024)
Ketamine induces multiple individually distinct whole-brain functional connectivity signatures (eLifeScience, April 17, 2024)
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial (Nature Scientific Reports, April 17, 2024)
High frequency deep brain stimulation of the dorsal raphe nucleus prevents methamphetamine priming-induced reinstatement of drug seeking in rats (Translational Psychiatry, April 16, 2024)
Understanding the patient and supporter journey in cocaine use disorder (Frontiers in Psychiatry, April 16, 2024)
Illicitly Manufactured Fentanyl Use Among Individuals in the U.S., 2022 (American Journal of Preventative Medicine, April 12, 2024)
Attitudes of Black American Christian church leaders toward Opioid Use Disorder, overdoses, and harm reduction: a qualitative study (Frontiers in Psychiatry, April 11, 2024)
Evidence-based whole person care for pregnant people who have opioid use disorder (SAMHSA, April 9, 2024)
Healthcare staff’s perspectives on long-acting injectable buprenorphine treatment: a qualitative interview study (Addiction Science and Clinical Practice, April 6, 2024)
The Management of Xylazine Overdose With Naloxone (Cureus, April 5, 2024)
Increased sensitivity for negative emotional images in individuals with problematic pornography use (Frontiers in Psychology, April 5, 2024)
Neuromodulation for Cannabis Use: A Scoping Review (Brain Sciences, April 5, 2024)
Willingness to provide a hair sample for drug testing: results from an anonymous multi-city intercept survey (American Journal of Alcohol and Drug Abuse, April 5, 2024)
Causal factors in childhood and adolescence leading to anabolic-androgenic steroid use: A machine learning approach (Drug and Alcohol Dependence, April 4, 2024)
Binge Drinking Among Sports Gamblers (free pdf download, JAMA Network Open, April 3, 2024)
The clinical use of cannabinoids for pain (World Journal of Advanced Research and Reviews, April 3, 2024)
Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder (free pdf download, JAMA Network Open, April 3, 2024)
Cost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study (Addiction Science and Clinical Practice, April 3, 2024)
Epigenome-wide association study on methamphetamine dependence (Addiction Biology, April 2, 2024)
Sequencing Hour-Level Temporal Patterns of Polysubstance Use Among Persons Who Use Cocaine, Alcohol, and Cannabis: A Back-Translational Approach (Drug and Alcohol Dependence, March 29, 2024)
Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases (JAMA Psychiatry, March 28, 2024)
Serial mediating effects of childhood trauma and conduct behaviors on the impact of family history among patients with alcohol use disorder (Nature Scientific Reports, March 27, 2024)
Efficacy of intravenous racemic ketamine and intranasal esketamine with dose escalation for treatment-resistant depression: A systematic review and meta-analysis (Journal of Affective Disorders, March 27, 2024)
Psilocybin enhances insightfulness in meditation (Nature Scientific Reports, March 27, 2024)
Urinary Retention Following Methamphetamine and Cannabis Abuse in a 33-Year-Old Male (Cureus, March 27, 2024)
The war on recovery (Stat, March 2024)
Treatment seeking for gambling disorder in nationwide register data (Frontiers in Public Health, March 26, 2024)
Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids (Frontiers in Public Health, March 26, 2024)
Recovery-supportive interventions for people with substance use disorders: a scoping review (Frontiers in Psychiatry, March 26, 2024)
Alcohol-related ED visits (SAMHSA, March 23, 2024)
AMA Overdose Epidemic Report 2023 (JAMA, March 23, 2024)
Providers perceptions of systems-level barriers and facilitators to utilizing family-based treatment approaches in adolescent and young adult opioid use disorder treatment (Addiction Science and Clinical Practice, March 21, 2024)
Co-occurrence of mental illness and substance use among US pregnant individuals, 2012-2021 (Psychiatric Research, March 20, 2024)
Terpenoid Synergy: UnPsychiatric veiling the Therapeutic Mosaic in the Treatment of Cannabinoid Addiction (Drug, Addiction and Therapeutics, March 18, 2024)
Sleep-Related Predictors of Risk for Alcohol Use and Related Problems in Adolescents and Young Adults (Alcohol Research: Current Reviews, March 18, 2024)
Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims (Addiction Science and Clinical Practice, March 17, 2024)
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study (Nature, March 15, 2024)
White House Challenge to Save Lives from Overdose (White House, March 13, 2024)
Association of Cannabis Use With Cardiovascular Outcomes Among US Adults (Journal of the American Heart Association, March 12, 2024)
Cannabis donation as a harm reduction strategy: a case study (Harm Reduction Journal, March 12, 2024)
Histories of violence among clients seeking substance use disorder treatment: a systematic mapping review (Frontiers in Psychiatry, March 12, 2024)
Clinical Practice Update on Diagnosis and Management of Cannabinoid Hyperemesis Syndrome: Commentary (Gastroenterology, March 8, 2024)
A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol (BMC Psychiatry, March 8, 2024)
Cannabis use and the prevalence of current asthma among adolescents and adults in the United States (Preventative Medicine, March 8, 2024)
Problematic pornography use across countries, genders, and sexual orientations: Insights from the International Sex Survey and comparison of different assessment tools (Addiction, March 8, 2024)
The association between marijuana and e-cigarette use and exercise behavior among adults (Preventative Medicine Reports, March 8, 2024)
The Rapidly Shifting Ketamine Landscape in the US (JAMA Open Network, March 7, 2024)
Clinical efficacy of adjunctive esketamine anesthesia in electroconvulsive therapy for major depressive disorders: A pragmatic, randomized, controlled trial (Psychiatric Research, March 7, 2024)
Methylphenidate (Ritalin) and Short-Term Cardiovascular Risk (Free pdf download, JAMA Open Network, March 6, 2024)
Apologizing for the Alcohol Industry? A Comment on ISFAR's Defense of Alcohol's Purported Health Benefits (Journal of Studies in Alcohol and Drugs, March 6, 2024)
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorder (Addiction Biology, March 6, 2024)
Deaths from Excessive Alcohol Use — United States, 2016–2021 (CDC, March 5, 2024)
Patient perspectives on current and potential therapies and clinical trial approaches for cocaine use disorder (Frontiers in Psychiatry, March 5, 2024)
Cardiotoxicity After Synthetic Cathinone Use (Cardiovascular Toxicity, February 29, 2024)
Integrating substance use peer support and screening brief intervention and referral to treatment services in the emergency department: a descriptive study of the ED leads program (Addiction Science and Clinical Practice, February 29, 2024)
Cannabidiol, cognition and schizophrenia: a narrative review (Exploration of Medicine, February 28, 2024)
The Overdose Crisis among U.S. Adolescents (New England Journal of Medicine, February 228, 2024. Access with free registration)
The Emergence of the Old Drug Captagon as a New Illicit Drug: A Narrative Review (Cureus, February 28, 2024)
Federal Policy Changes Must Occur to Provide a Lifesaving Stimulant Drug Intervention (Health Affairs Forefront, February 27, 2024)
The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder (Frontiers in Public Health, February 26, 2024)
Cannabis and Anxiety: A Critical Review (Medical Cannabis and Cannabinoids, February 26, 2024)
Predictors of response to intranasal ketamine in patients hospitalized for treatment-resistant depression (Personalized Medicine in Psychiatry, February 25, 2024)
Transcriptomic effects of paternal cocaine-seeking on the reward circuitry of male offspring (Translational Psychiatry, February 25, 2024)
FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders (FDA, February 23, 2024)
Incorporating harm reduction into alcohol use disorder treatment and recovery (National Institute on Alcohol and Alcohol Abuse/NIAAA, February 21, 2024)
Opioid Use After First Opioid Prescription in Children With Sickle Cell Disease (Free pdf downlaod, JAMA Pediatrics, February 20, 2024)
Cannabis Consumption and the Emergence of Giant Lung Bullae: A Case Report and Clinical Analysis (HCA, February 18, 2024)
Forensic implications of novel synthesis of cathinone derivatives (Forensic Chemistry, February 18, 2024)
Routes of Drug Use Among Drug Overdose Deaths — United States, 2020–2022 (CDC, February 15, 2024)
Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives (Addiction Science and Clinical Practice, February 14, 2024)
Fact Sheet 42 CFR Part 2 Final Rule (SAMHSA, February 8, 2024)
Opioid use disorder: current trends and potential treatments (Frontiers in Public Health, February 8, 2024)
Support your team and your guests: Tips for hosting a party including guests who may not be drinking (NIAAA Director's blog, February 7, 2024)
Proposed Framework for The ASAM Criteria, Fourth Edition: Correctional Settings & Community Reentry (ASAM, February 6, 2024)
Toward a Harm Reduction Approach to Cannabis Use Disorder (American Journal of Psychiatry, February 6, 2024)
Methamphetamine use shortens telomere length in male adults and rats (Drug and Alcohol Dependence, February 6, 2024)
Structural indices of brain aging in methamphetamine use disorder (Drug and Alcohol Dependence, February 6, 2024)
Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018 (BMC Public Health, February 6, 2024)
Impact of harm minimization interventions on reducing blood-borne infection transmission and some injecting behaviors among people who inject drugs: an overview and evidence gap mapping (Addiction Science and Clinical Practice, February 5, 2024)
A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery (Drug and Alcohol Dependence, February 2, 2024)
White House Drug Policy Director Statement on New Actions to Expand Access to Treatment and Save Lives (Office of National Drug Control Policy, February 2, 2024)
US trends in the association of suicide ideation/behaviors with marijuana use among adolescents ages 12–17 and differences by gender and race/ethnicity (Frontiers in Psychiatry, February 2, 2024)
Lisdexamfetamine-Induced Psychosis in a Patient With Neurodevelopmental Disorder (Cureus, February 2, 2024)
Justice Department Secures Agreement with Pennsylvania Courts to Resolve Lawsuit Concerning Discrimination Against People with Opioid Use Disorder (U.S. Department of Justice, February 2, 2024)
Cannabis Use and Car Crashes: A Review (Frontiers in Psychiatry, February 1, 2024)
Proceedings of the 19th annual conference of INEBRIA (Addiction Science and Clinical Practice, January 31, 2024)
Alcohol Information for Middle School (National Institute on Alcohol and Alcohol Abuse, January 31, 2024)
Genetics of gambling disorder and related phenotypes: The potential uses of polygenic and multifactorial risk models to enable early detection and improve clinical outcomes (Journal of Behavioral Addictions, January 26, 2024)
Consumer Guide: How Can a Peer Specialist Support My Recovery From Problematic Substance Use? (SAMHSA, January 25, 2024)
A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery (Addiction, January 25, 2024)
The cycle of solitude and avoidance: a daily life evaluation of the relationship between internet addiction and symptoms of social anxiety (Frontiers in Psychology, January 25, 2024)
Energy drink consumption and sleep parameters in college and university students: a national cross-sectional study (BMJ Open, January 24, 2024)
Recurrent cannabis-induced catatonia: a case report and comprehensive systematic literature review (Frontiers in Psychiatry, January 23, 2024)
Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials (Addiction, January 21, 2024)
Improving the quality of counseling and clinical supervision in opioid treatment programs: how can technology help? (Addiction Science and Clinical Practice, January 20, 2024)
Cannabis Use Among Students in Grades 8, 10, and 12, by Sex — King County, Washington, 2008–2021 (CDC, January 18, 2024)
Systemic Racism as a Determinant of Health Inequities for People With Substance Use Disorder (JAMA Psychiatry, January 18, 2024)
Prenatal Opioid Exposure and Immune-Related Conditions in Children (Free pdf download, JAMA Network Open, January 18, 2024)
Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation (Drug and Alcohol Dependence, January 17, 2024)
Minors and Online Marijuana Accessibility—Navigating the Digital Backdoors (JAMA Pediatrics, January 16, 2024)
Minors and Online Marijuana Accessibility—Navigating the Digital Backdoors—Reply (JAMA Pediatrics, January 16, 2024)
Optimizing methadone dose adjustment in patients with opioid use disorder (Frontiers in Psychiatry, January 16, 2024)
CFSRE Q4 2023 Novel Psychoactive Substances Trends Report (Center for Forensic Science Research Education, January 12, 2023)
CFSRE Novel Psychoactive Substances: 2023 Year in Review (Center for Forensic Science Research Education, January 12, 2023)
Substance use disorder bridge clinics: models, evidence, and future directions (Addiction Science and Clinical Practice, January 11, 2024)
Beyond Trauma-Informed: A Simple Tool to Support Survivors of Intimate Partner Violence (Addiction Technology Transfer System Network, January 9, 2024)
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders (Neuropsychopharmacology, January 9, 2024)
Evaluation of the multimodal DELTA therapy for adolescents with substance use disorders: an exploratory pilot trial (Frontiers in Psychiatry, January 9, 2024)
Benzodiazepine Discontinuation and Mortality Among Patients Receiving Long-Term Benzodiazepine Therapy (Free pdf download. JAMA Network Open, January 8, 2024)
Cannabidiol as a potential cessation therapeutic: Effects on intravenous nicotine self-administration and withdrawal symptoms in mice (Neuropharmacology, January 6, 2024)
Improving the quality of antenatal screening and early intervention for alcohol and other drug use: protocol for a multi-stage approach to systems reform (Addiction Science and Clinical Practice, January 6, 2024)
Hyperthermia, and Myocardial Injury in Three Young Adults Who Consumed Bromazolam Disguised as Alprazolam (CDC, January 5, 2024)
Ketamine cystitis following ketamine therapy for treatment-resistant depression – case report (BMC Psychiatry, January 2, 2024)
Psilocybin Without Psychotherapy: A Cart Without a Horse? (American Journal of Psychiatry, January 1, 2024)
Is Poorly Assisted Psilocybin Treatment an Increasing Risk? (American Journal of Psychiatry, January 1, 2024)
A novel syndrome associated with prenatal fentanyl exposure (Genetics in Medicine, December 29, 2023)
Cannabis use in the United States and its impact on gastrointestinal health (Nutrition in Clinical Practice, December 29, 2023)
Methadone Withdrawal-Related Psychosis in a Patient With Hormone-Dependent Breast Cancer (Cureus, December 28, 2023)
Benzodiazepine Use During Pregnancy and Risk of Miscarriage (JAMA Psychiatry, December 27, 2023)
Screen time and addictive use of gaming and social media in relation to health outcomes (Frontiers in Psychology, December 27, 2023)
The influence of peer’s social networks on adolescent’s cannabis use: a systematic review of longitudinal studies (Frontiers in Psychiatry, December 27, 2023)
Addiction and the brain: current knowledge, methods, and perspectives (Frontiers in Psychiatry, December 26, 2023)
Predictors of Multiwave Opioid Use Among Older American Adults (Innovations in Aging, December 23, 2023)
Oxycodone, an opioid like the others? (Frontiers in Psychiatry, December 21, 2023)
Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders (Addiction Neuroscience, December 15, 2023)
Adolescent alcohol disrupts development of noradrenergic neurons in the nucleus of the tractus solitarius and enhances stress behaviors in adulthood in mice in a sex specific manner (Addiction Neuroscience, December 15, 2023)
Editorial: Why we must act quickly and decisively to end the overdose epidemic (American Medical Association, December 15, 2023)
Validity of an online, self-administered Timeline Followback for alcohol use with adolescents (Frontiers in Psychiatry, December 15, 2023)
U.S. Senate Hearing on Older Adults and Substance Misuse (December 15, 2023)
Health Risks Associated with Smoking versus Injecting Fentanyl among People Who Use Drugs in California (Drug and Alcohol Dependence, December 15, 2023)
Past-Year Use Prevalence of Cannabidiol, Cannabigerol, Cannabinol, and Δ8-Tetrahydrocannabinol Among US Adults (JAMA Network Open, December 13, 2023)
Using ecological momentary assessments to understand how drinking during special occasions relates to parenting behaviors (Alcohol: Clinical and Experimental Research, December 13, 2023)
"Monitoring the Future" detailed graphs for 2022 (University of Michigan, December 13, 2023)
Acute Myocardial Infarction Associated With Amphetamine Use and Smoking in a Young Healthy Individual (Cureus, December 11, 2023)
Circulating metabolites may illustrate relationship of alcohol consumption with cardiovascular disease (BMC Medicine, December 8, 2023)
Effects of brief cognitive behavioral therapy on mental health in substance-related disorder: a randomized controlled trial (BMC Psychiatry, December 8, 2023)
Medetomidine: A new adulterant in street drugs (Fredric Rieders Foundation, December 8, 2023)
Advisory: Low Barrier Models of Care for Substance Use Disorders (SAMHSA, December 8, 2023)
Marijuana use linked with increased risk of heart attack, heart failure (American Heart Association, December 8, 2023)
Drug decriminalisation: grounding policy in evidence (Lancet, December 7, 2023)
Psilocybin in Bipolar II Study Provides Preliminary Data on Safety (JAMA Psychiatry, December 6, 2023)
“It feels like I’m coming to a friend’s house”: an interpretive descriptive study of an integrated care site offering injectable opioid agonist treatment (Addiction Science and Clinical Practice, December 3, 2023)
Overdose Prevention Centers, Crime, and Disorder in New York City (Free pdf download, JAMA Open Network, December 1, 2023)
Health status outcome among cannabis addicts after treatment of addiction (PLOS One, November 30, 2023)
Cannabinoid-Associated Hyperemesis Syndrome Treated With Dronabinol: Killing a Poison With the Poison (Cureus, November 30, 2023)
Mobile service delivery in response to the opioid epidemic in Philadelphia (Addiction Science and Clinical Practice, November 30, 2023)
Treatment Episode Data Set (TEDS) 2021: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies (SAMHSA, January 29, 2023)
Substance misuse programs in commercial aviation (National Academies of Sciences, Engineering and Medicine, January 29, 2023)
Beyond the Bottle: Niacin Deficiency and Chronic Alcoholism (Cureus, November 28, 2023)
Long-Term Cardiovascular Effects of Medications for Attention-Deficit/Hyperactivity Disorder—Balancing Benefits and Risks of Treatment (JAMA Psychiatry, November 25, 2023)
Abrupt Withdrawal From Chronic High-Dose Zolpidem Use: A Case Report of Resulting Delirium (Cureus, November 20, 2023)
Subthreshold opioid use disorder prevention (STOP) trial: a cluster randomized clinical trial: study design and methods (Addiction Science and Clinical Practice, November 19, 2023)
Brain Volume in Fetal Alcohol Spectrum Disorders Over a 20-Year Span (Free pdf download, JAMA Open Network, November 17, 2023)
The ascending limb of the cocaine unit dose–response function in rats as an experimental artifact (Scientific Reports, November 16, 2023)
Two subtypes of compulsive sexual behavior disorder (Frontiers in Psychiatry, November 16, 2023)
Lower cortical thickness and increased brain aging in adults with cocaine use disorder (Frontiers in Psychiatry, November 16, 2023)
Status of State Cannabis Legalization: November 2023
Results from the 2022 National Survey on Drug Use and Health: A Companion Infographic (SAMHSA, November 15, 2023)
Highlights from the National Survey on Drug Use and Health (SAMHSA, November 15, 2023)
Counseling Approaches To Promote Recovery From Problematic Substance Use and Related Issues Treatment Improvement Protocol (TIP) Series No. 65 (SAMHSA, November 14, 2023)
Marijuana: Forensics of Abuse, Medical Uses, Controversy, and AI (Forensic Sciences, November 11, 2023)
Adoption of Emergency Department–Initiated Buprenorphine for Patients With Opioid Use Disorder (Journal of the American Medical Association, November 11, 2023)
False or Misleading Claims in Online Direct-to-Consumer Ketamine Advertising (Free pdf download, Journal of the American Medical Association, November 11, 2023)
Drug Overdose Mortality Rates by Educational Attainment and Sex for Adults Aged 25–64 in the United States Before and During the COVID-19 Pandemic (Drug and Alcohol Dependence, November 8, 2023)
Alcohol and Skeletal Muscle in Health and Disease (Alcohol Research: Current Reviews, November 8, 2023)
Neural circuit selective for fast but not slow dopamine increases in drug reward (Nature Communications, November 8, 2023)
Stress and addictive disorders (Frontiers in Psychiatry, November 7, 2023)
Fungal and mycotoxin contaminants in cannabis and hemp flowers: implications for consumer health and directions for further research (Frontiers in Microbiology, November 3, 2023)
Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment (Free pdf download, JAMA Network Open, November 3, 2023)
Strategies to support substance use disorder care transitions from acute-care to community-based settings: a scoping review and typology (Addiction Science and Clinical Practice, November 3, 2023)
Cannabis use disorder, suicide attempts, and self-harm among adolescents (PLOS One, October 31, 2023)
Verbal memory and executive components of recall in adolescent binge drinkers (Frontiers in Psychology, October 31, 2023)
A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis (Frontiers in Psychiatry, October 31, 2023)
Concerns Related to the Consequences of Pediatric Cannabis Use: A 360-Degree View (Children, October 27, 2023)
Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems (Addiction Science and Clinical Practice, October 27, 2023)
Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice (Drug and Alcohol Dependence, October 27, 2023)
Self-reported adverse events associated with ∆8-Tetrahydrocannabinol (Delta-8-THC) Use (Journal of Cannabis Research, October 26, 2023)
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine? (JAMA Psychiatry, October 26, 2023)
Ketamine for depression—Knowns, unknowns, possibilities, barriers, and opportunities (JAMA Psychiatry, Ocotber 26, 2023)
A 13-item Health of the Nation Outcome Scale (HoNOS-13): validation by item response theory (IRT) in patients with substance use disorder (Addiction Science and Clinical Practice, October 25, 2023)
Consequences of adolescent drug use (Translational Psychiatry, October 24, 2023)
Brodifacoum in Synthetic Cannabinoids (Center for Forensic Research and Education, October 20, 2023)
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention (Frontiers in Psychiatry, October 19, 2023)
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff (Addiction Science and Clinical Practice, October 18, 2023)
EU Drug Market: Amphetamine — Key findings and threat assessment (European Centre for Drugs and Drug Monitoring, October 16, 2023)
Age-Adjusted Drug Overdose Death Rates Involving Cocaine by Region (CDC, October 13, 2023)
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment (Abstract only. JAMA Psychiatry, October 13, 2023)
The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders (Addiction Scuence and Clinical Practuce, October 12, 2023)
Hippocampal volume loss in individuals with a history of non-fatal opioid overdose (Addiction Biology, October 11, 2023)
Study protocol: implementing and evaluating a trauma-informed model of care in residential youth treatment for substance use disorders (Frontiers in Psychiatry, October 4, 2023)
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization (Free pdf download, JAMA Open Network, October 1, 2023)
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada (Addiction, September 30, 2023)
The association between temperature and alcohol- and substance-related disorder hospital visits in New York State (Communications Medicine, September 28, 2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study (Addiction Science and Clinical Practice, September 28, 2023)
A case of fatal overdose involving both hydromorphone and kratom (Journal of Forensic Sciences, September 27, 2023)
Potential effect of antidepressants on remission from cocaine use disorder (Drug and Alcohol Dependence, September 27, 2023)
Recovery incentives program: California's contingency management benefit (Preventive Medicine, September 27, 2023)
America's Opioid Ecosystem (Free book download, Rand Corporation, September 27, 2023)
Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings (Free pdf download, JAMA Open Network, September 27, 2023)
Manic episode following psilocybin use in a man with bipolar II disorder (Frontiers in Psychiatry, September 26, 2023)
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies (Frontiers in Psychiatry, September 26, 2023)
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023 (SAMHSA, September 25, 2023)
Reducing the risk of prenatal alcohol exposure and FASD through social services (Frontiers in Psychiatry, September 21, 2023)
Recovery from Substance Use and Mental Health Problems Among Adults in the United States (SAMHSA, September 20, 2023)
Antidepressant Effects of the Psychedelic Drug Psilocybin (New England Journal of Medicine, September 14, 2023)
How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit (BJPSYCH Bulletin, September 14, 2023)
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians (Psychiatric Research abd Clinical Practice, September 12, 2023)
Drug-related ED visits involving suicide attempts (SAMHSA, September 12, 2023)
E-Cigarettes and Stroke Risk (JAMA Neurology, September 12, 2023)
Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide 2023 (SAMHSA, September 11, 2023)
Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State (Cureus, September 8, 2023)
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (JAMA Psychiatry, September 7, 2023)
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs (Addiction Science and Clinical Practice, September 7, 2023)
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use (Addiction Science and Clinical Practice, September 4, 2023)
National Governors Association releases Roadmap for Tackling Drug Overdose Epidemic - (National Governors Association, September 2, 2023)
Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC, August 31, 2023)
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal (Free pdf download, JAMA Open Network, August 30, 2023)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients (Free pdf download, JAMA, August 30, 2023)
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample (Drug and Alcohol Dependence, August 25, 2023)
Cocaine hydrochloride, cocaine methiodide and methylenedioxypyrovalerone (MDPV) cause distinct alterations in the structure and composition of the gut microbiota (Nature, August 23, 2023)
Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits (Neuropsychopharmacology, August 23, 2023)
Confidence and risky decision-making in gambling disorder (Journal of Behavioral Addiction, August 22, 2023)
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult (Cureus, August 22, 2023)
A Systematic Review of the Association of Internet Gaming Disorder and Excessive Social Media Use With Psychiatric Comorbidities in Children and Adolescents (Cureus, August 21, 2023)
Unintentional Pediatric Ingestion of Cannabis—Addressing a Growing Public Health Risk (JAMA Pediatrics, August 21, 2023)
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model (Psychological Medicine, August 19, 2023)
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder (Addiction Science and Clinical Practice, August 17, 2023)
Impact of personalized alcohol intake and cognitive feedback on alcohol use behavior in hazardous drinkers: A quasi-randomized trial (Alcohol: Clinical and Experimental Reeaerch, August 16, 2023)
Prevalence and Factors Associated With Vaping Cannabidiol (CBD) Among US Adolescents (Free pdf download. JAMA Open Network, August 16, 2023)
After High School: Talking With Your Young Adult About Underage Drinking (Free pdf download. SAMHSA, August 16, 2023)
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (British Journal of Psychiatry, August 16. 2023)
Connecting Communities to Substance Use Services: Practical Tools for First Responders (Free pdf download, SAMHSA August 15, 2023)
The Future of Addiction Treatment Lies in Narrowing the Treatment Gap (ASAM News, August 15, 2023)
Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021 (Download free pdf. JAMA Network Open, August 12, 2023)
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study (Scripps Research, August 12, 2023)
Alcohol Consumption Among Adults With a Cancer Diagnosis (JAMA, August 11, 2023)
Integrating Opioid Use Disorder Treatment Into Primary Care Settings (JAMA, August 11, 2023)
High-Deductible Health Plans’ Impact on Mental Health and Substance Use Disorder Treatments—Balancing Cost and Care (JAMA Psychiatry, August 10, 2023)
Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review (Australian Psychiatry, August 10, 2023)
Fatal Drug Overdose Risks of Health Care Workers in the United States (Annals of Internal Medicine, August 9, 2023)
Monitoring the Future: National Survey Results on Drug Use, 1975-2022: Secondary School Students (University of Michigan, August 4, 2023)
Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations (Journal of Forensic Sciences, August 4, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, August 3, 2023)
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy (JAMA Psychiatry, August 3, 2023)
Psychedelics as Therapeutics—Potential and Challenges (JAMA Psychiatry, August 2, 2023)
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020 (JAMA Network Open, July 28, 2023)
Purple Haze: issues on cannabis legalization, volume II (Frontiers in Psychiatry, June 28, 2023)
Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in adolescents (British Journal of Psychiatry, July 26, 2023)
Involvement of the Opioid Peptide Family in Cancer Progression (Biomedicines, July 25, 2023)
Inhalation heroin use and leukoencephalopathy (Cureus, July 23, 2023)
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study (Addiction Science and Clinical Practice, July 19, 2023)
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011–2021 (CDC, July 19, 2023)
Guidelines for managing substance withdrawal in jails (US Department of Justice, July 18, 2022)
Multi-animal-model study reveals mutations in neural plasticity and nociception genes linked to excessive alcohol drinking (Alcohol: Clinical and Experimental Research, July 18, 2023)
Nucleus accumbens shell neurons’ early sensitivity to cocaine is associated with future increases in drug intake (Addiction Neuroscience, July 17, 2023}
Synthetic Cannabinoids-Related Cardiovascular Emergencies: A Review of the Literature (Cureus, July 16, 2023)
Should Suboxone Be Used to Treat Kratom Addiction?(Cureus, July 10, 2023)
The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema (Cureus, July 10, 2023)
Psychedelics reopen the social reward learning critical period (Nature, July 4, 2023)
Evaluation of Efficacy of Cannabis Use in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Review (Cureus, July 3, 2023)
E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022– March 31, 2023 (CDC, June 30, 2023)
A cross-national comparison of problematic gaming behavior and well-being in adolescents (Journal of Behavioral Addictions, June 30, 2023)
Personality dimensions of compulsive sexual behavior (Journal of Behavioral Addictions, June 30, 2023)
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention (Frontiers in Psychiatry, October 19, 2023)
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff (Addiction Science and Clinical Practice, October 18, 2023)
EU Drug Market: Amphetamine — Key findings and threat assessment (European Centre for Drugs and Drug Monitoring, October 16, 2023)
Age-Adjusted Drug Overdose Death Rates Involving Cocaine by Region (CDC, October 13, 2023)
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment (Abstract only. JAMA Psychiatry, October 13, 2023)
The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders (Addiction Scuence and Clinical Practuce, October 12, 2023)
Hippocampal volume loss in individuals with a history of non-fatal opioid overdose (Addiction Biology, October 11, 2023)
Study protocol: implementing and evaluating a trauma-informed model of care in residential youth treatment for substance use disorders (Frontiers in Psychiatry, October 4, 2023)
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization (Free pdf download, JAMA Open Network, October 1, 2023)
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada (Addiction, September 30, 2023)
The association between temperature and alcohol- and substance-related disorder hospital visits in New York State (Communications Medicine, September 28, 2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study (Addiction Science and Clinical Practice, September 28, 2023)
A case of fatal overdose involving both hydromorphone and kratom (Journal of Forensic Sciences, September 27, 2023)
Potential effect of antidepressants on remission from cocaine use disorder (Drug and Alcohol Dependence, September 27, 2023)
Recovery incentives program: California's contingency management benefit (Preventive Medicine, September 27, 2023)
America's Opioid Ecosystem (Free book download, Rand Corporation, September 27, 2023)
Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings (Free pdf download, JAMA Open Network, September 27, 2023)
Manic episode following psilocybin use in a man with bipolar II disorder (Frontiers in Psychiatry, September 26, 2023)
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies (Frontiers in Psychiatry, September 26, 2023)
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023 (SAMHSA, September 25, 2023)
Reducing the risk of prenatal alcohol exposure and FASD through social services (Frontiers in Psychiatry, September 21, 2023)
Recovery from Substance Use and Mental Health Problems Among Adults in the United States (SAMHSA, September 20, 2023)
Antidepressant Effects of the Psychedelic Drug Psilocybin (New England Journal of Medicine, September 14, 2023)
How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit (BJPSYCH Bulletin, September 14, 2023)
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians (Psychiatric Research abd Clinical Practice, September 12, 2023)
Drug-related ED visits involving suicide attempts (SAMHSA, September 12, 2023)
E-Cigarettes and Stroke Risk (JAMA Neurology, September 12, 2023)
Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide 2023 (SAMHSA, September 11, 2023)
Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State (Cureus, September 8, 2023)
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (JAMA Psychiatry, September 7, 2023)
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs (Addiction Science and Clinical Practice, September 7, 2023)
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use (Addiction Science and Clinical Practice, September 4, 2023)
National Governors Association releases Roadmap for Tackling Drug Overdose Epidemic - (National Governors Association, September 2, 2023)
Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC, August 31, 2023)
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal (Free pdf download, JAMA Open Network, August 30, 2023)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients (Free pdf download, JAMA, August 30, 2023)
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample (Drug and Alcohol Dependence, August 25, 2023)
Cocaine hydrochloride, cocaine methiodide and methylenedioxypyrovalerone (MDPV) cause distinct alterations in the structure and composition of the gut microbiota (Nature, August 23, 2023)
Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits (Neuropsychopharmacology, August 23, 2023)
Confidence and risky decision-making in gambling disorder (Journal of Behavioral Addiction, August 22, 2023)
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult (Cureus, August 22, 2023)
A Systematic Review of the Association of Internet Gaming Disorder and Excessive Social Media Use With Psychiatric Comorbidities in Children and Adolescents (Cureus, August 21, 2023)
Unintentional Pediatric Ingestion of Cannabis—Addressing a Growing Public Health Risk (JAMA Pediatrics, August 21, 2023)
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model (Psychological Medicine, August 19, 2023)
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder (Addiction Science and Clinical Practice, August 17, 2023)
Impact of personalized alcohol intake and cognitive feedback on alcohol use behavior in hazardous drinkers: A quasi-randomized trial (Alcohol: Clinical and Experimental Reeaerch, August 16, 2023)
Prevalence and Factors Associated With Vaping Cannabidiol (CBD) Among US Adolescents (Free pdf download. JAMA Open Network, August 16, 2023)
After High School: Talking With Your Young Adult About Underage Drinking (Free pdf download. SAMHSA, August 16, 2023)
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (British Journal of Psychiatry, August 16. 2023)
Connecting Communities to Substance Use Services: Practical Tools for First Responders (Free pdf download, SAMHSA August 15, 2023)
The Future of Addiction Treatment Lies in Narrowing the Treatment Gap (ASAM News, August 15, 2023)
Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021 (Download free pdf. JAMA Network Open, August 12, 2023)
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study (Scripps Research, August 12, 2023)
Alcohol Consumption Among Adults With a Cancer Diagnosis (JAMA, August 11, 2023)
Integrating Opioid Use Disorder Treatment Into Primary Care Settings (JAMA, August 11, 2023)
High-Deductible Health Plans’ Impact on Mental Health and Substance Use Disorder Treatments—Balancing Cost and Care (JAMA Psychiatry, August 10, 2023)
Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review (Australian Psychiatry, August 10, 2023)
Fatal Drug Overdose Risks of Health Care Workers in the United States (Annals of Internal Medicine, August 9, 2023)
Monitoring the Future: National Survey Results on Drug Use, 1975-2022: Secondary School Students (University of Michigan, August 4, 2023)
Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations (Journal of Forensic Sciences, August 4, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, August 3, 2023)
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy (JAMA Psychiatry, August 3, 2023)
Psychedelics as Therapeutics—Potential and Challenges (JAMA Psychiatry, August 2, 2023)
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020 (JAMA Network Open, July 28, 2023)
Purple Haze: issues on cannabis legalization, volume II (Frontiers in Psychiatry, June 28, 2023)
Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in adolescents (British Journal of Psychiatry, July 26, 2023)
Involvement of the Opioid Peptide Family in Cancer Progression (Biomedicines, July 25, 2023)
Inhalation heroin use and leukoencephalopathy (Cureus, July 23, 2023)
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study (Addiction Science and Clinical Practice, July 19, 2023)
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011–2021 (CDC, July 19, 2023)
Guidelines for managing substance withdrawal in jails (US Department of Justice, July 18, 2022)
Multi-animal-model study reveals mutations in neural plasticity and nociception genes linked to excessive alcohol drinking (Alcohol: Clinical and Experimental Research, July 18, 2023)
Nucleus accumbens shell neurons’ early sensitivity to cocaine is associated with future increases in drug intake (Addiction Neuroscience, July 17, 2023}
Synthetic Cannabinoids-Related Cardiovascular Emergencies: A Review of the Literature (Cureus, July 16, 2023)
Should Suboxone Be Used to Treat Kratom Addiction?(Cureus, July 10, 2023)
The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema (Cureus, July 10, 2023)
Psychedelics reopen the social reward learning critical period (Nature, July 4, 2023)
Evaluation of Efficacy of Cannabis Use in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Review (Cureus, July 3, 2023)
E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022– March 31, 2023 (CDC, June 30, 2023)
A cross-national comparison of problematic gaming behavior and well-being in adolescents (Journal of Behavioral Addictions, June 30, 2023)
Personality dimensions of compulsive sexual behavior (Journal of Behavioral Addictions, June 30, 2023)
Patients with cognitive deficits and substance use disorders, a clinical population in need of focused attention (Frontiers in Psychiatry, October 19, 2023)
Impact of COVID-19-related methadone regulatory flexibilities: views of state opioid treatment authorities and program staff (Addiction Science and Clinical Practice, October 18, 2023)
EU Drug Market: Amphetamine — Key findings and threat assessment (European Centre for Drugs and Drug Monitoring, October 16, 2023)
Age-Adjusted Drug Overdose Death Rates Involving Cocaine by Region (CDC, October 13, 2023)
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment (Abstract only. JAMA Psychiatry, October 13, 2023)
The temporal association between suicide and comorbid mental disorders in people treated for substance use disorders (Addiction Scuence and Clinical Practuce, October 12, 2023)
Hippocampal volume loss in individuals with a history of non-fatal opioid overdose (Addiction Biology, October 11, 2023)
Study protocol: implementing and evaluating a trauma-informed model of care in residential youth treatment for substance use disorders (Frontiers in Psychiatry, October 4, 2023)
Cannabis-Involved Traffic Injury Emergency Department Visits After Cannabis Legalization and Commercialization (Free pdf download, JAMA Open Network, October 1, 2023)
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, Canada (Addiction, September 30, 2023)
The association between temperature and alcohol- and substance-related disorder hospital visits in New York State (Communications Medicine, September 28, 2023)
Exploring dog ownership in the lives of people with substance use disorder: a qualitative study (Addiction Science and Clinical Practice, September 28, 2023)
A case of fatal overdose involving both hydromorphone and kratom (Journal of Forensic Sciences, September 27, 2023)
Potential effect of antidepressants on remission from cocaine use disorder (Drug and Alcohol Dependence, September 27, 2023)
Recovery incentives program: California's contingency management benefit (Preventive Medicine, September 27, 2023)
America's Opioid Ecosystem (Free book download, Rand Corporation, September 27, 2023)
Technology-Assisted Buprenorphine Treatment in Rural and Nonrural Settings (Free pdf download, JAMA Open Network, September 27, 2023)
Manic episode following psilocybin use in a man with bipolar II disorder (Frontiers in Psychiatry, September 26, 2023)
Sex difference in alcohol withdrawal syndrome: a scoping review of clinical studies (Frontiers in Psychiatry, September 26, 2023)
Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide 2023 (SAMHSA, September 25, 2023)
Reducing the risk of prenatal alcohol exposure and FASD through social services (Frontiers in Psychiatry, September 21, 2023)
Recovery from Substance Use and Mental Health Problems Among Adults in the United States (SAMHSA, September 20, 2023)
Antidepressant Effects of the Psychedelic Drug Psilocybin (New England Journal of Medicine, September 14, 2023)
How to quit cannabis when you have a mental illness: study from the perspective of patients who have successfully quit (BJPSYCH Bulletin, September 14, 2023)
Validation of Two Diagnostic Assessments for Opioid and Stimulant Use Disorder for Use by Non‐Clinicians (Psychiatric Research abd Clinical Practice, September 12, 2023)
Drug-related ED visits involving suicide attempts (SAMHSA, September 12, 2023)
E-Cigarettes and Stroke Risk (JAMA Neurology, September 12, 2023)
Engaging Community Coalitions to Decrease Opioid Overdose Deaths Practice Guide 2023 (SAMHSA, September 11, 2023)
Cocaine-Induced Four-Extremity Ischemia Caused by a Hypercoagulable State (Cureus, September 8, 2023)
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (JAMA Psychiatry, September 7, 2023)
Piloting the integration of SMART Recovery into outpatient alcohol and other drug treatment programs (Addiction Science and Clinical Practice, September 7, 2023)
Measuring time in buprenorphine treatment stages among people with HIV and opioid use disorder by retention definition and its association with cocaine and hazardous alcohol use (Addiction Science and Clinical Practice, September 4, 2023)
National Governors Association releases Roadmap for Tackling Drug Overdose Epidemic - (National Governors Association, September 2, 2023)
Drug Overdose Deaths with Evidence of Counterfeit Pill Use — United States, July 2019–December 2021 (CDC, August 31, 2023)
Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use Is Legal (Free pdf download, JAMA Open Network, August 30, 2023)
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients (Free pdf download, JAMA, August 30, 2023)
Association between cannabis use disorder symptom severity and probability of clinically-documented diagnosis and treatment in a primary care sample (Drug and Alcohol Dependence, August 25, 2023)
Cocaine hydrochloride, cocaine methiodide and methylenedioxypyrovalerone (MDPV) cause distinct alterations in the structure and composition of the gut microbiota (Nature, August 23, 2023)
Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits (Neuropsychopharmacology, August 23, 2023)
Confidence and risky decision-making in gambling disorder (Journal of Behavioral Addiction, August 22, 2023)
Management of New Onset Amphetamine-Induced Acute Decompensated Heart Failure in a Young Adult (Cureus, August 22, 2023)
A Systematic Review of the Association of Internet Gaming Disorder and Excessive Social Media Use With Psychiatric Comorbidities in Children and Adolescents (Cureus, August 21, 2023)
Unintentional Pediatric Ingestion of Cannabis—Addressing a Growing Public Health Risk (JAMA Pediatrics, August 21, 2023)
Cost-effectiveness of psilocybin-assisted therapy for severe depression: exploratory findings from a decision analytic model (Psychological Medicine, August 19, 2023)
A qualitative study of interest in and preferences for potential medications to treat methamphetamine use disorder (Addiction Science and Clinical Practice, August 17, 2023)
Impact of personalized alcohol intake and cognitive feedback on alcohol use behavior in hazardous drinkers: A quasi-randomized trial (Alcohol: Clinical and Experimental Reeaerch, August 16, 2023)
Prevalence and Factors Associated With Vaping Cannabidiol (CBD) Among US Adolescents (Free pdf download. JAMA Open Network, August 16, 2023)
After High School: Talking With Your Young Adult About Underage Drinking (Free pdf download. SAMHSA, August 16, 2023)
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (British Journal of Psychiatry, August 16. 2023)
Connecting Communities to Substance Use Services: Practical Tools for First Responders (Free pdf download, SAMHSA August 15, 2023)
The Future of Addiction Treatment Lies in Narrowing the Treatment Gap (ASAM News, August 15, 2023)
Perceptions of Safety of Daily Cannabis vs Tobacco Smoking and Secondhand Smoke Exposure, 2017-2021 (Download free pdf. JAMA Network Open, August 12, 2023)
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study (Scripps Research, August 12, 2023)
Alcohol Consumption Among Adults With a Cancer Diagnosis (JAMA, August 11, 2023)
Integrating Opioid Use Disorder Treatment Into Primary Care Settings (JAMA, August 11, 2023)
High-Deductible Health Plans’ Impact on Mental Health and Substance Use Disorder Treatments—Balancing Cost and Care (JAMA Psychiatry, August 10, 2023)
Guidelines and treatment for illicit drug related presentations in emergency departments: A scoping review (Australian Psychiatry, August 10, 2023)
Fatal Drug Overdose Risks of Health Care Workers in the United States (Annals of Internal Medicine, August 9, 2023)
Monitoring the Future: National Survey Results on Drug Use, 1975-2022: Secondary School Students (University of Michigan, August 4, 2023)
Detection of fentanyl, synthetic opioids, and ketamine in hair specimens from purposive samples of American and Italian populations (Journal of Forensic Sciences, August 4, 2023)
Cannabis Use Disorder and Subsequent Risk of Psychotic and Nonpsychotic Unipolar Depression and Bipolar Disorder (JAMA Psychiatry, August 3, 2023)
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy (JAMA Psychiatry, August 3, 2023)
Psychedelics as Therapeutics—Potential and Challenges (JAMA Psychiatry, August 2, 2023)
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020 (JAMA Network Open, July 28, 2023)
Purple Haze: issues on cannabis legalization, volume II (Frontiers in Psychiatry, June 28, 2023)
Association of cannabis, cannabidiol and synthetic cannabinoid use with mental health in adolescents (British Journal of Psychiatry, July 26, 2023)
Involvement of the Opioid Peptide Family in Cancer Progression (Biomedicines, July 25, 2023)
Inhalation heroin use and leukoencephalopathy (Cureus, July 23, 2023)
Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study (Addiction Science and Clinical Practice, July 19, 2023)
Co-involvement of Opioids in Drug Overdose Deaths Involving Cocaine and Psychostimulants, 2011–2021 (CDC, July 19, 2023)
Guidelines for managing substance withdrawal in jails (US Department of Justice, July 18, 2022)
Multi-animal-model study reveals mutations in neural plasticity and nociception genes linked to excessive alcohol drinking (Alcohol: Clinical and Experimental Research, July 18, 2023)
Nucleus accumbens shell neurons’ early sensitivity to cocaine is associated with future increases in drug intake (Addiction Neuroscience, July 17, 2023}
Synthetic Cannabinoids-Related Cardiovascular Emergencies: A Review of the Literature (Cureus, July 16, 2023)
Should Suboxone Be Used to Treat Kratom Addiction?(Cureus, July 10, 2023)
The Double-Edged Sword: Naloxone-Induced Noncardiogenic Pulmonary Edema (Cureus, July 10, 2023)
Psychedelics reopen the social reward learning critical period (Nature, July 4, 2023)
Evaluation of Efficacy of Cannabis Use in Patients with Attention Deficit Hyperactivity Disorder: A Systematic Review (Cureus, July 3, 2023)
E-Cigarette–Associated Cases Reported to Poison Centers — United States, April 1, 2022– March 31, 2023 (CDC, June 30, 2023)
A cross-national comparison of problematic gaming behavior and well-being in adolescents (Journal of Behavioral Addictions, June 30, 2023)
Personality dimensions of compulsive sexual behavior (Journal of Behavioral Addictions, June 30, 2023)
Copyright © 2023, JRW Behavioral Health Services. All Rights Reserved.
Powered by GoDaddy